ESMO Virtual Congress 2020: Long-Term Results of Enfortumab Vedotin Monotherapy for Locally Advanced or Metastatic Urothelial Cancer in the EV-201 Study in Patients Previously Treated with Platinum and PD-1/PD-L1 Inhibitors

(UroToday.com) It is well-known that locally advanced and metastatic urothelial carcinoma is an incurable disease with poor overall survival (OS), especially in patients who progress on or after platinum-containing chemotherapy.